Caption Management, LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $91,273 - $150,059	22,100 Added 44.2%	72,100 $445,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $249,000 - $338,500	50,000 New	50,000 $299,000
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $919,452 - $1.37 Million	-115,800 Reduced 74.33%	40,000 $333,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $889,350 - $1.2 Million	84,700 Added 119.13%	155,800 $1.79 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $5.77 Million - $7.92 Million	-534,600 Reduced 88.26%	71,100 $895,000
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $932,598 - $2.11 Million	118,200 Added 24.25%	605,700 $6.41 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $2.51 Million - $4.3 Million	217,500 Added 80.56%	487,500 $7.93 Million
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $1.4 Million - $1.93 Million	-125,000 Reduced 31.65%	270,000 $3.74 Million
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $6.96 Million - $8.65 Million	-490,000 Reduced 55.37%	395,000 $5.68 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $7.51 Million - $13.6 Million	790,000 Added 831.58%	885,000 $14 Million
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $700,150 - $1.29 Million	95,000 New	95,000 $966,000
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $50,000 - $74,600	-20,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.91 - $9.15 $58,200 - $183,000	20,000 New	20,000 $76,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.